Inspire Medical Systems reported a GAAP loss of $16.694 million for the 3 months of 2022, up 2.9% from $16.216 million in the prior year. Revenue increased 71.9% to $69.382 million from $40.352 million a year earlier.

Inspire Medical Systems' GAAP loss for 2021 was $42.042 million, down 26.5% from $57.203 million the previous year. Revenue doubled to $233.394 million from $115.381 million a year earlier.

Inspire Medical Systems reported a GAAP loss of $39.651 million for 9M 2021, down 20.2% from $49.719 million in the previous year. Revenue increased 2.2 times to $154.996 million from $69.372 million a year earlier.

Inspire Medical Systems' GAAP loss for the six months of 2021 was $29.304 million, down 25.5% from $39.334 million in the prior year. Revenue increased 2.8 times to $93.311 million from $33.53 million a year earlier.